Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Impact on Innovation Efficient Public Transit Systems in Tokyo and Zurich Highlight Economic Benefits of Urban Mobility Investment OpenAI Reportedly Nears Confidential IPO Filing Signaling a Landmark Moment for AI Sector Karan Dayanidhi Maran Launches MicroDrama Platform KadhaiShorts with PayPerSeries Model Japan Consumer Goods Firm Warns of Vicious Stagflation in Indonesia Amit Shahs UCC Exemption Pledge Potential Economic Implications for Tribal Regions in BJPRuled States LightPath Technologies Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Rally Unexpectedly Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss Meets Optimism in Gene Therapy Pipeline MSN Q1 2024 Earnings Narrowing Losses Amid Limited Revenue Disclosure Stock Surges 2026 Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up LSBK Q3 2025 Earnings EPS of 032 Stands Alone Amid Sparse Disclosure KOF Q1 2026 Earnings EPS Misses Estimates by 152 Stock Declines Otter Tail Corporation OTTR Holds Near Support as Trading Activity Remains Subdued Caesarstone CSTE Declines 76 as Shares Approach Key Support Level Strategic Education Inc STRA Slips 1 as Stock Tests Near Support Levels New York Times NYT Holds Steady Near 75 as Digital Subscription Growth Fuels Modest Gains Invesco Municipal Opportunity Trust VMO Edges Higher Amid Stable Municipal Bond Market NEN Q4 2024 Earnings Strong PerUnit Earnings Highlight Steady Real Estate Performance ANTX Q1 2026 Earnings Biotech Reports WiderthanExpected Loss Shares Climb ONEOK Q1 2026 Earnings Modest EPS Beat as Operational Efficiency Drives Performance Michelin Retires Green Star Award Leaving Sustainable Chefs Disappointed BUDA Q1 2026 Earnings Earnings Beat Estimates by 634 as EPS Surges to 005 Tokenization May Create Free Market in Capital Says Strategys Michael Saylor Honeywells Quantinuum IPO Could Test Quantum Computing Stock Rally USAC Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Minerva Neurosciences NERV Edges Lower as Stock Tests Key Support Zone